𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II trial of m-AMSA in head and neck cancer

✍ Scribed by Arlene A. Forastiere; Charles W. Young; Robert E. Wittes

Publisher
Springer
Year
1981
Tongue
English
Weight
160 KB
Volume
6
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II trial of mitoxantrone in head a
Phase II trial of mitoxantrone in head and neck cancer
✍ Matti S. Aapro; Davis S. Alberts πŸ“‚ Article πŸ“… 1984 πŸ› Springer US 🌐 English βš– 136 KB

Mitoxantrone (l,4-dihydroxy-5,8-bis((2-[(2-hydroxyethyl)amino]ethyl)amino)-9, 10 anthracenedione dihydrochloride, NSC 301,739) is a new aminoanthraquinone derivative with clinical activity in the treatment of advanced breast cancer (1, 2), lymphoma (3), and acute leukemia (4). We have carried out a

Phase ii trial of etoposide and doxorubi
Phase ii trial of etoposide and doxorubicin in advanced head and neck cancer
✍ Gradishar, William J. ;Vokes, Everett E. ;Kies, Merrill S. πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 388 KB

## Abstract In an effort to improve the response rate of patients with advanced head and neck cancer, a clinical trial combining two infrequently studied drugs was conducted. Twelve patients with squamous cell carcinoma of the head and neck were treated with 3‐day continuous infusions of etoposide